Pharmaceutical compositions comprising hGH for oral delivery

Details for Australian Patent Application No. 2007289344 (hide)

Owner Novartis AG

Inventors Patel, Ashish Bipin; Joshi, Yatindra; Azria, Moise; Mindeholm, Linda; Lobrutto, Rosario

Agent Davies Collison Cave

Pub. Number AU-B-2007289344

PCT Pub. Number WO2008/027854

Priority 60/824,140 31.08.06 US

Filing date 28 August 2007

Wipo publication date 6 March 2008

Acceptance publication date 14 April 2011

International Classifications

A61K 31/198 (2006.01)

A61K 38/06 (2006.01) Medicinal preparations containing peptides - Tripeptides

A61K 38/27 (2006.01) Medicinal preparations containing peptides - Growth hormone (GH) (Somatotropin)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/00 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61P 5/06 (2006.01) Drugs for disorders of the endocrine system

Event Publications

5 March 2009 PCT application entered the National Phase

  PCT publication WO2008/027854 Priority application(s): WO2008/027854

14 April 2011 Application Accepted

  Published as AU-B-2007289344

11 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007289350-Polymer rods for spinal applications

2007289338-Transcription factors for differentiation of adult human olfactory progenitor cells